- Home
- RRGB vs ADAG Comparison
RRGB vs ADAG Comparison
Compare RRGB & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RRGB | ADAG |
|---|---|---|
| Founded | 1969 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.5M | 84.8M |
| IPO Year | 2002 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RRGB | ADAG |
|---|---|---|
| Price | $4.09 | $1.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $9.67 | $8.00 |
| AVG Volume (30 Days) | ★ 190.7K | 51.8K |
| Earning Date | 11-10-2025 | 08-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,226,409,000.00 | $103,204.00 |
| Revenue This Year | N/A | $6,983.06 |
| Revenue Next Year | N/A | $36.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.50 | $1.30 |
| 52 Week High | $7.89 | $3.16 |
Technical Indicators
Market Signals| Indicator | RRGB | ADAG |
|---|---|---|
| Relative Strength Index (RSI) | 42.52 | 51.32 |
| Support Level | $3.98 | $1.74 |
| Resistance Level | $4.35 | $1.89 |
| Average True Range (ATR) | 0.17 | 0.13 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 21.21 | 80.30 |
Price Performance
Historical ComparisonAbout RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.